Bacteremia and endocarditis due to methicillin-resistant Staphylococcus aureus: the potential role of daptomycin

References

• ArbeitRDMakiDTallyFPThe safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infectionsClin Infect Dis20043816738115227611
   PubMed Web of Science ®Google Scholar
• BaddourLMWilsonWRBayerASInfective endocarditis: Diagnosis, antimicrobial therapy, and management of complications a statement for healthcare professionals from the Committee on rheumatic fever, endocarditis, and kawasaki disease, council on cardiovascular disease in the young, and the councils on clinical cardiology, stroke, and cardiovascular surgery and anesthesia, American heart association - Executive summaryCirculation2005111316784
   Web of Science ®Google Scholar
• BenvenutoMBenzigerDPYankelevSPharmacokinetics and tolerability of daptomycin at doses up to 12 milligrams per kilogram of body weight once daily in healthy volunteersAntimicrob Agents Chemother2006503245917005801
   PubMed Web of Science ®Google Scholar
• CarpenterCFChambersHFDaptomycin: Another novel agent for treating infections due to drug-resistant gram-positive pathogensClin Infect Dis200438994100015034832
   PubMed Web of Science ®Google Scholar
• CDCStaphylococcus aureus resistant to vancomycin – United States, 2002MMWR. Morbidity and mortality weekly report200251565712139181
   PubMedGoogle Scholar
• CDCCommunity-associated methicillin-resistant Staphylococcus aureus Infections in Pacific Islanders – Hawaii, 2001–2003MMWR. Morbidity and mortality weekly report2004537677015329653
   PubMedGoogle Scholar
• ChaRBrownWJRybakMJBactericidal activities of daptomycin, quinupristin-dalfopristin, and linezolid against vancomycin-resistant Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetationsAntimicrob Agents Chemother2003473960314638509
   PubMed Web of Science ®Google Scholar
• ChangF-YMacDonaldBBPeacockJEJrA prospective multicenter study of Staphylococcus aureus bacteremia: Incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistanceMedicine2003a823223214530781
   PubMed Web of Science ®Google Scholar
• ChangF-YPeacockJEJrMusherDM Staphylococcus aureus bacteremia: Recurrence and the impact of antibiotic treatment in a prospective multicenter studyMedicine2003b82333914530782
   PubMed Web of Science ®Google Scholar
• ChirouzeCCabellCHFowlerVGJrPrognostic factors in 61 cases of Staphylococcus aureus prosthetic valve infective endocarditis from the international collaboration on endocarditis merged databaseClin Infect Dis2004381323715127349
   PubMed Web of Science ®Google Scholar
• [CLSI] Clinical and Laboratory Standards InstitutePerformance Standards for Antimicrobial Susceptibility Testing: 16th Informational Supplement. CLSI document M100-S16Wayne2006PANCCLS
   Google Scholar
• CosgroveSESakoulasGPerencevichENComparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: A meta-analysisClin Infect Dis200336535912491202
   PubMed Web of Science ®Google Scholar
• Cubist Pharmaceuticals IncCubicin full prescribing information2006 Accessed 25 January, 2007. URL: http://www.cubicin.com/2006_full_pi.pdf
   Google Scholar
• CuiLTominagaENeohH-MHiramatsuKCorrelation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureusAntimicrob Agents Chemother20065010798216495273
   PubMed Web of Science ®Google Scholar
• DeRykeCASutherlandCZhangBSerum bactericidal activities of high dose daptomycin with and without coadministration of gentamicin against isolates of Staphylococcus aures and Enterococcus speciesAntimicrob Agents Chemother20065035293417065618
   PubMed Web of Science ®Google Scholar
• EdwardsCMKingKGarciaRJEarly-onset rhabdomyolysis associated with daptomycinInfect Dis Clin Pract2006143278
   Google Scholar
• FortúnJGrillFMartin-DávilaPTreatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapyJ Antimicrob Chemother20065881682116899468
   PubMed Web of Science ®Google Scholar
• FowlerVGJrBoucherHWCoreyGRDaptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureusN Engl J Med20063556536516914701
   PubMed Web of Science ®Google Scholar
• FowlerVGJrMiroJMHoenBStaphylococcus aureus endocarditis: A consequence of medical progressJAMA200529330122115972563
   PubMed Web of Science ®Google Scholar
• FowlerVGJrOlsenMKCoreyGRClinical identifiers of complicated Staphylococcus aureus bacteremiaArch Intern Med200316320667214504120
   PubMed Web of Science ®Google Scholar
• FowlerVGJrSandersLLSextonDJOutcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: Experience with 244 patientsClin Infect Dis199827478869770144
   PubMed Web of Science ®Google Scholar
• FrenchGLBactericidal agents in the treatment of MRSA infections – the potential role of daptomycinJ Antimicrob Chemother20065811071717040922
   PubMed Web of Science ®Google Scholar
• GemmellCGEdwardsDIFraiseAPGuidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UKJ Antimicrob Chemother20065758960816507559
   PubMed Web of Science ®Google Scholar
• HanbergerHNilssonLEMallerRPharmacodynamics of daptomycin and vancomycin on Enterococcus faecalis and Staphylococcus aureus demonstrated by studies of initial killing and postantibiotic effect and influence of Ca2+ and albumin on these drugsAntimicrob Agents Chemother1991351710161659305
   PubMed Web of Science ®Google Scholar
• HaydenMKRezaiKHayesRADevelopment of daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus J Clin Micro20054352857
   PubMed Web of Science ®Google Scholar
• HidayatLKHsuDIQuistRHigh-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infectionsArch Int Med200616621384417060545
   PubMed Web of Science ®Google Scholar
• JevonsMP“Celbenin”-resistant StaphylococciBMJ196111245
   Web of Science ®Google Scholar
• KazoryADibadjKWeinerIDRhabdomyolysis and acute renal failure in a patient treated with daptomycinJ Antimicrob Chemother200657578916410267
   PubMed Web of Science ®Google Scholar
• KhatibRJohnsonLBFakihMGPersistence in staphylococcus aureus bacteremia: Incidence, characteristics of patients and outcomeScand J Infect Dis20063871416338832
   PubMed Web of Science ®Google Scholar
• KhatibRRiedererKSaeedSTime to positivity in Staphylococcus aureus bacteremia: Possible correlation with the source and outcome of infectionClin Infect Dis200541594816080079
   PubMed Web of Science ®Google Scholar
• KhatibRSaeedSSharmaMImpact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremiaEur J Clin Microbio Infect Dis2006251815
   PubMed Web of Science ®Google Scholar
• LampKCRybakMJBaileyEMIn vitro pharmocodynamic effects on concentration, pH, and growth phase, on serum bactericidal activities, of daptomycin and vancomycinAntimicrob Agents Chemother1992362709241336344
   PubMed Web of Science ®Google Scholar
• LaPlanteKLRybakMJImpact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic modelAntimicrob Agents Chemother20044846657215561842
   PubMed Web of Science ®Google Scholar
• LevineDPFrommBSReddyBRSlow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditisAnn Intern Med1991115674801929035
   PubMed Web of Science ®Google Scholar
• LodiseTPMcKinnonPSSwiderskiLOutcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremiaClin Infect Dis20033614182312766837
   PubMed Web of Science ®Google Scholar
• LuperchioSAMortinLISilvermanJAMIC Shifts in patients treated for Staphylococcus aureus bacteremia and infective endocarditisProgram and abstracts of the 46^th ICAAC2006Washington D.C.ASM Abstract L-1206
   Google Scholar
• MangiliABicaISnydmanDRDaptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremiaClin Infect Dis20054010586015825002
   PubMed Web of Science ®Google Scholar
• MarkowitzNQuinnELSaravolitzLDTrimethoprim sulfamethoxasole compared with vancomycin for the treatment of Staphylococcus aureus infectionAnn Intern Med199211739081503330
   PubMed Web of Science ®Google Scholar
• MermelLAFarrBMSheretzRJGuidelines for the management of intravascular catheter-related infectionsClin Infect Dis20013212497211303260
   PubMed Web of Science ®Google Scholar
• McKinnonPSKreugerTSLampKCDeterminants of clinical outcomes in patients treated with daptomycin for Gram-positive infectionProgram and abstracts of the 46th ICAAC2006Washington D.C.ASM Abstract K–782
   Google Scholar
• MiroJMArgueraICabellCH Staphylococcus aureus native valve infective endocarditis: Report of 566 episodes from the International Collaboration on Endocarditis Merged DatabaseClin Infect Dis415071416028160
   PubMed Web of Science ®Google Scholar
• Moise-BroderPEl-FawalNForrestARelationship of prior vancomycin use and daptomycin MICs in patients with MRSA bacteremiaProgram and abstracts of the 46th ICAAC2006Washington D.C.ASM Abstract C2–1151
   Google Scholar
• Moise-BroderPASakoulasGEliopoulosGMAccessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapyClin Infect Dis2004381700515227615
   PubMed Web of Science ®Google Scholar
• MoranGJKrishnadasanAGorwitzRJMethicillin-resistant S aureus infections among patients in the emergency departmentN Engl J Med20063556667416914702
   PubMed Web of Science ®Google Scholar
• NNIS SystemNational nosocomial infections surveillance (NNIS) system report, data summary from January 1992 through June 2004, issued October 2004Am J Infect Control2004324708515573054
   PubMed Web of Science ®Google Scholar
• NoskinGARubinRJSchentagJJThe burden of Staphylococcus aureus infections on hospitals in the United StatesArch Intern Med200516517566116087824
   PubMed Web of Science ®Google Scholar
• OlesonFBJrBermanCLKirkpatrickJBOnce-daily dosing in dogs optimizes daptomycin safetyAntimicrob Agents Chemother20004429485311036005
   PubMed Web of Science ®Google Scholar
• PaezASBrownRBWilkPARapid loss of daptomycin susceptibility in methicillin-resistant Staphylococcus aureus blood culture isolates from an infective endocarditis patientInfect Dis Clin Practice2006143224
   Google Scholar
• PatelJBJevittLAHagemanJAn association between reduced susceptibility to daptomycin and reduced susceptibility to vancomycin in Staphylococcus aureus Clin Infect Dis2006421652316652325
   PubMed Web of Science ®Google Scholar
• RosenABFowlerVGJrCoreyGRCost-effectiveness of transesophageal echocardiography to determine the duration of therapy for intravascular catheter-associated Staphylococcus aureus bacteremiaAnn Intern Med19991308102010366370
   PubMed Web of Science ®Google Scholar
• SakoulasGAlderJThauvin-EliopoulosCInduction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycinAntimicrob Agents Chemother2006501581516569891
   PubMed Web of Science ®Google Scholar
• SakoulasGEliopoulosGMMoelleringRCJrAccessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycinAntimicrob Agents Chemother200246149250211959587
   PubMed Web of Science ®Google Scholar
• SegretiJACrankCWFinneyMSDaptomycin for the treatment of Gram-positive bacteremia and infective endocarditis: a retrospective case series of 31 patientsPharmacotherapy2006263475216503714
   PubMed Web of Science ®Google Scholar
• SeyboldUKourbatovaEVJohnsonJGEmergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infectionsClin Infect Dis2006426475616447110
   PubMed Web of Science ®Google Scholar
• SilvermanJAMortinLIVanpraaghADInhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impactJ Infect Dis200519121495215898002
   PubMed Web of Science ®Google Scholar
• SmallPMChambersHFVancomycin for Staphylococcus aureus endocarditis in intravenous drug usersAntimicrob Agents Chemother1990341227312393284
   PubMed Web of Science ®Google Scholar
• TallyFPDeBruinMFDevelopment of daptomycin for Gram-positive infectionsJ Antimicrob Chemother200046523611020247
   PubMed Web of Science ®Google Scholar
• TsujiBTRybakMJShort-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetationsAntimicrob Agents Chemother20054927354515980344
   PubMed Web of Science ®Google Scholar
• VikramHRHavillNLKoethLMClinical progression of methicillin-resistant Staphylococcus aureus vertebral osteomyeltis associated with reduced susceptibility to daptomycinJ Clin Micro20054353837
   Web of Science ®Google Scholar
• VoycihJMBraughtonKRSurdevantDEInsights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophilsJ Immunol200517539071916148137
   PubMed Web of Science ®Google Scholar